Does EPIRUBICIN Cause Interstitial lung disease? 174 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Interstitial lung disease have been filed in association with EPIRUBICIN (Ellence). This represents 1.1% of all adverse event reports for EPIRUBICIN.
174
Reports of Interstitial lung disease with EPIRUBICIN
1.1%
of all EPIRUBICIN reports
15
Deaths
84
Hospitalizations
How Dangerous Is Interstitial lung disease From EPIRUBICIN?
Of the 174 reports, 15 (8.6%) resulted in death, 84 (48.3%) required hospitalization, and 11 (6.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPIRUBICIN. However, 174 reports have been filed with the FAERS database.
What Other Side Effects Does EPIRUBICIN Cause?
Nausea (1,265)
Vomiting (978)
Myelosuppression (934)
Neutropenia (926)
White blood cell count decreased (873)
Febrile neutropenia (809)
Diarrhoea (749)
Asthenia (732)
Pyrexia (729)
Fatigue (685)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which EPIRUBICIN Alternatives Have Lower Interstitial lung disease Risk?
EPIRUBICIN vs EPLERENONE
EPIRUBICIN vs EPLONTERSEN
EPIRUBICIN vs EPOETIN ALFA-EPBX
EPIRUBICIN vs EPOGEN
EPIRUBICIN vs EPOPROSTENOL